Relationship between HbA1cand risk of all-cause hospital admissions among people with Type 2 diabetes

Low HbA1c and mortality: causation and confounding

(2012) M. K. Rutter   DIABETOLOGIA

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETOLOGIA

Concentration–Response Function for Ozone and Daily Mortality: Results from Five Urban and Five Rural U.K. Populations

(2012) Richard W. Atkinson et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Nationwide Study on Trends in Hospital Admissions for Major Cardiovascular Events and Procedures Among People With and Without Diabetes in England, 2004-2009

(2011) E. P. Vamos et al.   DIABETES CARE

Standards of Medical Care in Diabetes--2012

(2011)   DIABETES CARE

Diabetes inpatients: a case of lose, lose, lose. Is it time to use a ‘diabetes-attributable hospitalization cost’ to assess the impact of diabetes?

(2011) D. Simmons et al.   DIABETIC MEDICINE

Miscoding, misclassification and misdiagnosis of diabetes in primary care

(2011) S. de Lusignan et al.   DIABETIC MEDICINE

Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2011) L. Govan et al.   DIABETOLOGIA

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

(2011) S. Zoungas et al.   DIABETOLOGIA

Effects of Intensive Glucose Lowering in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

(2010) Matthew C. Riddle   CIRCULATION

Rates and Determinants of Coronary and Abdominal Aortic Artery Calcium Progression in the Veterans Affairs Diabetes Trial (VADT)

(2010) A. Saremi et al.   DIABETES CARE

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study

(2010) A. P. Kengne et al.   DIABETOLOGIA

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

(2010) Craig J Currie et al.   LANCET

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults

(2010) Elizabeth Selvin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial

(2009) S. Zoungas et al.   DIABETES CARE

Intensive glucose control and macrovascular outcomes in type 2 diabetes

(2009) F. M. Turnbull et al.   DIABETOLOGIA

Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway

(2009) A. C. Dale et al.   EUROPEAN HEART JOURNAL

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

(2009) Kausik K Ray et al.   LANCET

Patients with Type 2 Diabetes Undergoing Coronary Artery Bypass Graft Surgery: Predictors of Outcomes

(2008) Christi Deaton et al.   European Journal of Cardiovascular Nursing

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE